Harvard Bioscience Inc. (HBIO) Declined -5.17% or -0.24 To Price $4.4 On Thursday


Harvard Bioscience Inc. (HBIO) declined -5.17% or -0.24 to $4.4. It is near 42170 shares traded, which is 27.59% compare to the average total volume 152862. The market cap of HBIO is $160.95 million. The year to date change is 35.43%. The 52 week price range is from $2.95 to $6.7. Price of HBIO have changed 2.65% during last week. It have changed -13.27% over last month, -9.02% over last 3 months, -21.36% over last 6 months and 25.41% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for HBIO is 5.50. It is 25.00% above current price. The 200-day Moving Averages for HBIO is 5.05. It is 14.77% above current price. The 52-week High is 6.7. It is 52.27% from the current price. The 52-week Low is 2.95. It is -32.95% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of HBIO is 9.48 on 2018-09-28. Short % to float is 4.89%. There are some statistics of HBIO. It is has market cap $160.95 million. The share outstanding is 36.58 million. The average volume is 152862. The revenue is 25.05M. It has 5.84M cash and 12.44M in debt. The gross profit is 11.64M. The percent of top 15 Institution holding is 72.80%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of HBIO is -6.43%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of HBIO is -3.58%.


Tags:

Share this post